BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 22683330)

  • 21. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4.
    Schelbergen RF; Blom AB; van den Bosch MH; Slöetjes A; Abdollahi-Roodsaz S; Schreurs BW; Mort JS; Vogl T; Roth J; van den Berg WB; van Lent PL
    Arthritis Rheum; 2012 May; 64(5):1477-87. PubMed ID: 22127564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Up-regulation of S100A8 and S100A9 protein in bronchial epithelial cells by lipopolysaccharide.
    Henke MO; Renner A; Rubin BK; Gyves JI; Lorenz E; Koo JS
    Exp Lung Res; 2006 Sep; 32(8):331-47. PubMed ID: 17090475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological roles of S100A8 and S100A9 in cutaneous squamous cell carcinoma in vivo and in vitro.
    Choi DK; Li ZJ; Chang IK; Yeo MK; Kim JM; Sohn KC; Im M; Seo YJ; Lee JH; Kim CD; Lee Y
    Arch Dermatol Res; 2014 Jul; 306(5):489-96. PubMed ID: 24550082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S100A8 and S100A9, both transcriptionally regulated by PU.1, promote epithelial-mesenchymal transformation (EMT) and invasive growth of dermal keratinocytes during scar formation post burn.
    Xu Z; Cheng C; Kong R; Liu Y; Wang S; Ma Y; Xing X
    Aging (Albany NY); 2021 Jun; 13(11):15523-15537. PubMed ID: 34099591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Observational study on Swedish plaque psoriasis patients receiving narrowband-UVB treatment show decreased S100A8/A9 protein and gene expression levels in lesional psoriasis skin but no effect on S100A8/A9 protein levels in serum.
    Duvetorp A; Söderman J; Assarsson M; Skarstedt M; Svensson Å; Seifert O
    PLoS One; 2019; 14(3):e0213344. PubMed ID: 30865695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S100A8 and S100A9 proteins form part of a paracrine feedback loop between pancreatic cancer cells and monocytes.
    Nedjadi T; Evans A; Sheikh A; Barerra L; Al-Ghamdi S; Oldfield L; Greenhalf W; Neoptolemos JP; Costello E
    BMC Cancer; 2018 Dec; 18(1):1255. PubMed ID: 30558665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity.
    Leukert N; Vogl T; Strupat K; Reichelt R; Sorg C; Roth J
    J Mol Biol; 2006 Jun; 359(4):961-72. PubMed ID: 16690079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of S100A8/A9 in HaCaT keratinocytes alters the rate of cell proliferation and differentiation.
    Voss A; Bode G; Sopalla C; Benedyk M; Varga G; Böhm M; Nacken W; Kerkhoff C
    FEBS Lett; 2011 Jan; 585(2):440-6. PubMed ID: 21192933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S100A8/S100A9 deficiency increases neutrophil activation and protective immune responses against invading infective L3 larvae of the filarial nematode Litomosoides sigmodontis.
    Frohberger SJ; Fercoq F; Neumann AL; Surendar J; Stamminger W; Ehrens A; Karunakaran I; Remion E; Vogl T; Hoerauf A; Martin C; Hübner MP
    PLoS Negl Trop Dis; 2020 Feb; 14(2):e0008119. PubMed ID: 32107497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer.
    Ehrchen JM; Sunderkötter C; Foell D; Vogl T; Roth J
    J Leukoc Biol; 2009 Sep; 86(3):557-66. PubMed ID: 19451397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secretion of the Phosphorylated Form of S100A9 from Neutrophils Is Essential for the Proinflammatory Functions of Extracellular S100A8/A9.
    Schenten V; Plançon S; Jung N; Hann J; Bueb JL; Bréchard S; Tschirhart EJ; Tolle F
    Front Immunol; 2018; 9():447. PubMed ID: 29593718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity.
    Nacken W; Roth J; Sorg C; Kerkhoff C
    Microsc Res Tech; 2003 Apr; 60(6):569-80. PubMed ID: 12645005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S100a8/a9 released by CD11b+Gr1+ neutrophils activates cardiac fibroblasts to initiate angiotensin II-Induced cardiac inflammation and injury.
    Wu Y; Li Y; Zhang C; A X; Wang Y; Cui W; Li H; Du J
    Hypertension; 2014 Jun; 63(6):1241-50. PubMed ID: 24711518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of Nrf2 activation in the upregulation of S100A9 by exposure to inorganic arsenite.
    Sumi D; Shimizu Y; Himeno S
    Int J Mol Med; 2013 Jan; 31(1):259-64. PubMed ID: 23165982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
    Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
    J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. S100A8/A9 stimulates keratinocyte proliferation in the development of squamous cell carcinoma of the skin via the receptor for advanced glycation-end products.
    Iotzova-Weiss G; Dziunycz PJ; Freiberger SN; Läuchli S; Hafner J; Vogl T; French LE; Hofbauer GF
    PLoS One; 2015; 10(3):e0120971. PubMed ID: 25811984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phagocyte-specific S100A8/A9 is upregulated in primary Sjögren's syndrome and triggers the secretion of pro-inflammatory cytokines in vitro.
    Nicaise C; Weichselbaum L; Schandene L; Gangji V; Dehavay F; Bouchat J; Balau B; Vogl T; Soyfoo MS
    Clin Exp Rheumatol; 2017; 35(1):129-136. PubMed ID: 27749214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer.
    Grebhardt S; Veltkamp C; Ströbel P; Mayer D
    Int J Cancer; 2012 Dec; 131(12):2785-94. PubMed ID: 22505354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells.
    Hermani A; De Servi B; Medunjanin S; Tessier PA; Mayer D
    Exp Cell Res; 2006 Jan; 312(2):184-97. PubMed ID: 16297907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.